Collection of proposed, operating, demonstration, and pilot study potable reuse systems across the U.S. as of 2020. Information includes project name, location, augmentation type, capacity, year operational, treatment train, and source water type. References are included in this submission. As potable reuse facilities undergo expansions or upgrades, treatment trains and capacities are subject to change. Operational status may also change. Treatment trains listed are reported to the detail that the source provides. Type and doses of chemical post-treatment or chlorination is often not specified. Please see README section in spreadsheet for definitions of acronyms used.

Although endocrine disrupting compounds have been detected in wastewater and surface waters worldwide using a variety of in vitro effects-based screening tools, e.g. bioassays, few have examined potential attenuation of environmental contaminants by both natural (sorption, degradation, etc.) and anthropogenic (water treatment practices) processes. This study used several bioassays and quantitative chemical analyses to assess residence-time weighted samples at six sites along a river in the northeastern United States beginning upstream from a wastewater treatment plant outfall and proceeding downstream along the stream reach to a drinking water treatment plant. Known steroidal estrogens were quantified and changes in signaling pathway molecular initiating events (activation of estrogen, androgen, glucocorticoid, peroxisome proliferator-activated, pregnane X receptor, and aryl hydrocarbon receptor signaling networks) were identified in water extracts. In initial multi-endpoint assays geographic and receptor-specific endocrine activity patterns in transcription factor signatures and nuclear receptor activation were discovered. In subsequent single endpoint receptor-specific bioassays, estrogen (16 of 18 samples; 0.01 to 28 ng estradiol equivalents [E2Eqs]/L) glucocorticoid (3 of 18 samples; 1.8 to 21 ng dexamethasone equivalents [DexEqs]/L), and androgen (2 of 18 samples; 0.95 to 2.1 ng dihydrotestosterone equivalents [DHTEqs]/L) receptor transcriptional activation occurred above respective assay method detection limits (0.04 ng E2Eqs/L, 1.2 ng DexEqs/L, and 0.77 ng DHTEqs/L) in multiple sampling events. Estrogen activity, the most often detected, correlated well with measured concentrations of known steroidal estrogens (r2 = 0.890). Overall, activity indicative of multiple types of endocrine active compounds was highest in wastewater effluent samples, while activity downstream was progressively lower, and negligible in unfinished treated drinking water. Not only was estrogenic and glucocorticoid activity confirmed in the effluent by utilizing multiple methods concurrently, but other activated signaling networks that historically received less attention (i.e. peroxisome proliferator-activated receptor) were also detected. This dataset is associated with the following publication: Medlock Kakaley, E., B. Blackwell, M. Cardon, J. Conley, N. Evans, D. Feifarek, E. Furlong, S. Glassmeyer, L. Gray, P. Hartig, D. Kolpin, M. Mills, L. Rosenblum, D. Villeneuve, and V. Wilson. De Facto Water Reuse: Bioassay suite approach delivers depth and breadth in endocrine active compound detection. SCIENCE OF THE TOTAL ENVIRONMENT. Elsevier BV, AMSTERDAM, NETHERLANDS, 699(134297): 1, (2020).